The Oxford-AstraZeneca vaccine is best suited for Africa according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi.
Professor Madhi is leading the clinical trial of the vaccine locally.
He said the vaccine isn’t only effective but also affordable.
The Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
The ongoing late-stage trial is taking place at 150 global sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.
More Stories
Zuma Rescission Application Denied
State Capture Commission Seeks Another Extension
IEC Ready For Voter Registration Weekend
NICD Reports 4 215 New COVID-19 Cases In SA
ANC Slams Carl Niehaus
Another Soldier Arrested For Cross-Border Vehicle Smuggling
Deputy Minister Hlengiwe Mkhize Dies At 69
SA Reports 4 667 New COVID-19 Cases
Matric Exams to start on 27 October
HSF Wants Court To Set Aside Fraser Decision On Zuma Parole
Judge Hlophe Heads To Court
SA Reports 3 699 New COVID-19 Cases